Allopurinol shortage — AU supply status & alternatives

Allopurinol

ATC M04AA01

🇦🇺 AUST R 384901

In shortage · Australia

Allopurinol Alphapharm

In declared shortage · 🇦🇺 Australia & also short in🇨🇦 CA🇺🇸 US🇮🇪 IE🇳🇱 NL🇳🇴 NO

Critical shortage

Product discontinued / no longer available on the Australian market.

Reading today’s signals…

🇦🇺 AUAEMPA$3.50DPMQ A$21.84details →

• Can I substitute?

No pathway on record

prescriber decision required

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

Product attributes reference data we hold

Active ingredient (INN)	Allopurinol
Brand names	Allopurinol Alphapharm
ATC level 5	M04AA01
ATC level 4	M04AA
Therapeutic category	Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper
Controlled substance	No
Marketing-authorisation holders	TEVA UK LIMITED, PHARMVIT LIMITED, WAYMADE PLC, STRIDES PHARMA UK LIMITED +3 more
Registrations on file	12
Patient information leaflet (PIL)	Not on file
Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 PBS · July 2026

🇦🇺 AU

● Official price on file

Ex-manufacturer

A$3.50

AEMP

Dispensed (DPMQ)

A$21.84

incl. fees

Pack

allopurinol 300 mg tablet, 60

Source: PBSEffective July 2026 · AUD

Other markets

🇬🇧 GB

£0.65

Drug Tariff

🇺🇸 US

US$0.03

Acquisition

🇫🇷 FR

€1.53

Retail price

🇮🇹 IT

€2.07

Retail price

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

16 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Low concentration risk

Haleos Labs LTDIol Chemicals And Pharmaceuticals LTDExemed PharmaceuticalsTapi Nl BVSigna SA De CvMatrix Pharmacorp Private LTD+10 more

Manufacturing countries: India, Spain, Taiwan, China · Source: FDA List of Drug Master Files

Shortage status by regulator official notices

🇦🇺

Australia

TGA · 4h ago

Critical

🇨🇦

Canada

HC · 3h ago

Medium

🇺🇸

United States

FDA · 3h ago

Medium

🇳🇴

Norway

NOMA · 22h ago

Resolved

🌐

IMA · 1d ago

Resolved

🇳🇱

Netherlands

CBG-MEB · 2d ago

Medium

🇮🇪

Ireland

HPRA · 1mo ago

Medium

Recalls official enforcement reports

🇺🇸

ALLOPURINOL

Dr. Reddy's Laboratories, Inc. · June 2024

Class IIdetails ↗

🇺🇸

Allopurinol Tablets

Preferred Pharmaceuticals, Inc. · Jan 2023

Class IIdetails ↗

🇺🇸

ALLOPURINOL

Accord Healthcare, Inc. · Jan 2023

Class IIdetails ↗

🇺🇸

ALLOPURINOL

CARDINAL HEALTHCARE · Jan 2022

Class IIdetails ↗

🇺🇸

ALOPRIM

Mylan Institutional LLC · May 2020

Class IIdetails ↗

🇺🇸

ALLOPURINOL

Qualitest Pharmaceuticals · July 2015

Class IIIdetails ↗

Verified timeline regulator events

🇳🇱 30 June 2026

medium reported

🇳🇱 15 June 2026

medium reported

🇳🇴 21 May 2026

medium reported

🇳🇱 16 Apr 2026

medium reported

🇨🇦 14 Apr 2026

medium reported

🇺🇸 19 Feb 2026

medium reported

Sources official regulators

🇨🇦

verified 3h ago

verify ↗

🇺🇸

FDA

verified 3h ago

verify ↗

🇦🇺

TGA

verified 4h ago

verify ↗

🇳🇴

NOMA

verified 22h ago

verify ↗

🌐

IMA

verified 1d ago

verify ↗

🇳🇱

CBG-MEB

verified 2d ago

verify ↗

🇮🇪

HPRA

verified 1mo ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders12 registrations · 7 MA holders

Product	Strength	Form	Market	MA holder	Status
Tih	100mg	—	🇦🇺 AU	—	Active
Tih	300mg	—	🇦🇺 AU	—	Active
ALLOPURINOL 100 MG TABLETS	100 MG	tablet	🇬🇧 GB	TEVA UK LIMITED	Active
ALLOPURINOL 100MG TABLETS	100MG	tablet	🇬🇧 GB	PHARMVIT LIMITED	Active
ALLOPURINOL 300MG TABLETS	300MG	tablet	🇬🇧 GB	PHARMVIT LIMITED	Active
Allopurinol Tablets Bp	100MG	tablet	🇬🇧 GB	WAYMADE PLC	Active
Allopurinol Tablets Bp	300MG	tablet	🇬🇧 GB	WAYMADE PLC	Active
ALLOPURINOL TABLETS 100MG	100MG	tablet	🇬🇧 GB	STRIDES PHARMA UK LIMITED	Active
ALLOPURINOL 300 MG TABLETS	300 MG	tablet	🇬🇧 GB	CRESCENT PHARMA LIMITED	Active
Cosuric/Allopurinol	100MG	tablet	🇬🇧 GB	CHELONIA HEALTHCARE LIMITED	Active
Cosuric/Allopurinol	300MG	tablet	🇬🇧 GB	CHELONIA HEALTHCARE LIMITED	Active
ALLOPURINOL 200MG TABLETS	200MG	tablet	🇬🇧 GB	ASPIRE PHARMA LIMITED	Active

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.